The University of Liverpool was founded as a college in 1881 and gained its royal charter in 1903. It is one of the six original ‘redbrick’ civic universities, with the mission of advancement of learning and ennoblement of life. The University of Liverpool is ranked in the top 1% of universities worldwide and is a founding member of the Russell Group, a collaboration of twenty leading research-intensive universities, and the N8 Group for research collaboration. The university is composed of 3 Faculties, Faculty of Health and Life Sciences, Faculty of Humanities and Social Sciences and Faculty of Science and Engineering, and 55 academic departments, which offer over 400 undergraduate and postgraduate courses to our 22,000+ students. As a member of the elite Russell Group, the University of Liverpool attracts strong research funding, with 81% of our research rated world-leading and internationally excellent, and an annual research income of £98.7m (2018-2019). The University of Liverpool has been active participants in European funding, including Horizon 2020 and its predecessor FP7. Over the last ten years, the University has participated in over 300 European funded programmes. This includes 111 Horizon 2020 projects, with a combined research budget of over £40M.
The Faculty of Health & Life Sciences at the University of Liverpool is one of UK’s leading centres for health and life science research and education. The Faculty has over 1850 research and teaching active staff to support 5,000 undergraduates and 1,000 postgraduate students. The Faculty is unique as the only organisation of the kind to offer scientific and clinical education that spans the full range of biosciences, clinical medicine, health sciences, dentistry, veterinary science and tropical medicine. Through our partnerships with the NHS, industry and academia, we also host and support numerous Centres of Excellence in fields ranging from drug safety and personalised medicine to zoonosis and dairy farming. The Faculty of Health & Life Sciences have been involved in over 2000 research projects in last 5 years, with a combined value in excess of £400M, 54 of which are Horizon 2020 programmes of work.
The Liverpool Centre for Cardiovascular Sciences (LCCS) directed by Professor Gregory Lip, Price-Evans Chair of Cardiovascular Medicine, has been operational since 1 February 2019. Its mission statement is “Supporting the citizens of the Liverpool City Region to live healthier lives, free of cardiovascular diseases and stroke.” The LCCS has been formed as a strategic research collaboration among Liverpool Heart & Chest Hospital, Liverpool John Moores University, Liverpool Health Partners, and the University of Liverpool (follow us @LiverpoolCCS) LCCS brings together a multidisciplinary group of academic (clinical/non-clinical) and NHS researchers into a truly cross-university, cross-department collaboration (‘research without boundaries’).
The University of Liverpool will undertake the following areas of research for the project:
(1) Assessment of anxiety and depression, health-related quality of life (HRQoL) and cognitive impairment over time in patients with atrial fibrillation (AF) who survive an intracranial haemorrhage (ICH).
(2) To explore, in an embedded qualitative sub-study, patient and physician’s attitudes to antithrombotic treatment (DOAC, antiplatelet therapy or no therapy) among AF patients who are ICH-survivors.
View All Partners